TRACE: Selexipag ACT-293987, AC-065A404 A multicenter double-blind placebo controlled Phase 4 study in patients with pulmonary arterial hypertension to assess the effect of selexipag

Administered By

Awarded By

Contributors

Start/End

  • January 24, 2018 - December 14, 2020